Membrane Glycoproteins
These glycosylated proteins embedded within the lipid bilayer are involved in a wide range of physiological and pathological processes, making them important targets for biomedical research.
Membrane glycoproteins mediate interactions between cells and their extracellular environment, facilitating the transduction of signals across the cell membrane.
They are involved in processes such as cell-cell recognition, immune response, and disease pathogenesis.
Studying the structure, function, and regulation of membrane glycoproteins can provide valuable insights into fundamental biological mechanisms and support the development of novel therapeutic strategies.
Reserchers leveraging the power of PubCompare.ai can effeciently locate the best protocols from literature, preprints, and patents to enhance the reproducibility and accuracy of their membrane glycoprotein studies, unlocking new discoveries.
Most cited protocols related to «Membrane Glycoproteins»
Protocol full text hidden due to copyright restrictions
Open the protocol to access the free full text link
Protocol full text hidden due to copyright restrictions
Open the protocol to access the free full text link
Most recents protocols related to «Membrane Glycoproteins»
Example 13
The instant study is designed to test the efficacy in cotton rats of candidate hMPV vaccines against a lethal challenge using an hMPV vaccine comprising mRNA encoding Fusion (F) glycoprotein, major surface glycoprotein G, or a combination of both antigens obtained from hMPV. Cotton rats are challenged with a lethal dose of the hMPV.
Animals are immunized intravenously (IV), intramuscularly (IM), or intradermally (ID) at week 0 and week 3 with candidate hMPV vaccines with and without adjuvant. Candidate vaccines are chemically modified or unmodified. The animals are then challenged with a lethal dose of hMPV on week 7 via IV, IM or ID. Endpoint is day 13 post infection, death or euthanasia. Animals displaying severe illness as determined by >30% weight loss, extreme lethargy or paralysis are euthanized. Body temperature and weight are assessed and recorded daily.
In experiments where a lipid nanoparticle (LNP) formulation is used, the formulation may include a cationic lipid, non-cationic lipid, PEG lipid and structural lipid in the ratios 50:10:1.5:38.5. The cationic lipid is DLin-KC2-DMA (50 mol %) or DLin-MC3-DMA (50 mol %), the non-cationic lipid is DSPC (10 mol %), the PEG lipid is PEG-DOMG (1.5 mol %) and the structural lipid is cholesterol (38.5 mol %), for example.
Example 12
The instant study is designed to test the immunogenicity in mice of candidate hMPV vaccines comprising a mRNA polynucleotide encoding Fusion (F) glycoprotein, major surface glycoprotein G, or a combination thereof, obtained from hMPV.
Mice are immunized intravenously (IV), intramuscularly (IM), or intradermally (ID) with candidate vaccines. Candidate vaccines are chemically modified or unmodified. A total of four immunizations are given at 3-week intervals (i.e., at weeks 0, 3, 6, and 9), and sera are collected after each immunization until weeks 33-51. Serum antibody titers against Fusion (F) glycoprotein or major surface glycoprotein (G) protein are determined by ELISA. Sera collected from each mouse during weeks 10-16 are pooled, and total IgG purified. Purified antibodies are used for immunoelectron microscopy, antibody-affinity testing, and in vitro protection assays.
to the most important features of the structure of SARS-CoV-2. The
four major structural proteins are displayed: the envelope (E), membrane
(M), nucleocapsid (N), and spike (S) proteins (
kDa) is the surface glycoprotein anchored to the viral membrane that
plays an essential role when the infection process of SARS-CoV-2 takes
place. This protein is a trimer of three identical protomers (
contains three segments: a short intracellular tail (IC), a transmembrane
anchor (TM), and a large ectodomain that extends outward from the
virus which is coated with sugar chains to hide the virus from the
immune system8 (link) and comprises S1 and S2
subunits.
Next, the students are invited to study the ectodomain by analyzing
the requested structural features that they must observe manipulating
PyMOL.
Although hundreds of structures of this spike protein
are already
available in the Protein Data Bank, the one with the code
They are encouraged to distinguish the four different levels of the
protein structures: primary, secondary, tertiary, and quaternary,
changing the representation of the molecule from lines or wireframe
to cartoon.
They must learn how to select individual residues
or different
chains, how to change their colors, how to generate objects, how to
show and hide different parts of the protein, how to measure distances
and angles for bonds, and how to generate surfaces.
They have
to realize that the spike protein is a complex of three
identical chains. A schematic illustration of the spike protein (
students, and they must recognize every single domain in the ectodomain,
extracting them as different objects and coloring them in the suggested
color.
The S1 subunit has an N-terminal
domain (NTD) and a receptor-binding
domain (RBD) located in the C-terminal domain, which is implied in
recognition and binding to the host cell receptor. S2 consists of
the fusion peptide (FP), two heptad repeats 1 (HR1 and HR2) which
operate the fusion of viral and host membranes, a transmembrane domain
(TM), and a cytoplasmic tail (CT).
When different species of
coronavirus are compared, the S2 subunit
is highly conserved, but the sequence of the S1 subunit varies greatly.
S1 and S2 are connected to the S1/S2 cleavage site in which specific
proteases act. The cleavage transforms the spike protein into a fusion
competent form that suffers several conformational changes and allows
it to anchor to the host membrane leading to the membrane fusion.10 (link)
The samples analyzed in this study were collected opportunistically and archived in the molecular lab at the Biodiversity Conservation Center, Sauraha, in CNP. They included sera from 28 tigers and 20 leopards. Captures took place between 2011 and 2021 and were carried out jointly by the Department of National Parks and Wildlife Conservation (DNPWC) and the National Trust for Nature Conservation (NTNC). Almost all (47/48) captures were conducted as part of routine wildlife management and conflict resolution. The only exception to this was a single tiger, which was captured as part of a collaring study in 2021. Animals were immobilized using a standard protocol of medetomidine (0.07 mg/kg) and ketamine (3 mg/kg) delivered intramuscularly via dart gun or hand injection. Blood samples were collected during immobilization, and the separated serum was archived at −20 °C.
Most tigers (26/28) were captured in and around the Chitwan–Parsa Complex (CPC; 27°46′ N, 84°53′ E) which includes CNP, PNP and the surrounding buffer zones. The remaining two tigers were captured in or around the Bardia–Banke Complex (BBC; 28°33′ N, 81°65′ E) which includes BNP, BaNP and the surrounding buffers zones. Meanwhile, most leopards (17/20) were captured in the central Mid-hill districts, two were captured in the CPC and one was captured in Koshi Thappu Wildlife Reserve (KTWR; 26°65′ N, 87°00′ E).
Prior to testing, all samples were heat inactivated at 56 °C for 30 min. A modified version of a previously described serum neutralization test [52 (link)] was used to screen the heat-inactivated samples. This protocol uses an engineered cell line, HEK293dogSLAM, which expresses the canine signaling lymphocytic activation molecule (SLAM-F1, the receptor used by CDV for cell entry) and a replication deficient vesicular stomatitis virus pseudotype expressing hemagglutinin and fusion surface glycoproteins from the Onderstepoort strain of CDV. The referenced protocol was adapted by substituting green fluorescent protein (GFP) for luciferase as the marker for infection [12 (link)]. Cell lines HEK293dogSLAM and HEK293T were supplied by the University of Glasgow. Tests were read by examining wells using an inverted fluorescent microscope under low power. Dilutions which achieved a 90% reduction in the number of infected cells compared to the mean count of four serum-free controls were considered to have effectively neutralized the virus.
All samples were tested in quadruplicate using a 1:16 serum dilution along with a panel of 20 dog sera as positive controls. Samples which tested positive on the initial assay were re-tested to determine the titer using four-fold serial serum dilutions from 1:16 to 1:16,384. The Spearman–Karber method [53 ] was then used to calculate the final titer. Samples with a titer of 1:16 or greater were considered positive. Seroprevalence was calculated as the number of animals testing positive, which was divided by the total number of animals tested and expressed with 95% binomial confidence intervals. Population comparisons were conducted using a two-proportions z-test in R [54 ]. Results were reviewed in conjunction with the clinical histories for the individuals concerned.
Mortality records from the Central Zoo in Lalitpur and in CNP were reviewed for the period September 2019 to September 2022 to identify additional tigers and leopards that had suffered fatal neurological disease, which was characterized by seizures.
Top products related to «Membrane Glycoproteins»
More about "Membrane Glycoproteins"
These glycosylated proteins embedded within the lipid bilayer are involved in a wide range of physiological and pathological processes, making them important targets for biomedical research.
Membrane glycoproteins mediate interactions between cells and their extracellular environment, facilitating the transduction of signals across the cell membrane.
They are involved in processes such as cell-cell recognition, immune response, and disease pathogenesis.
Studying the structure, function, and regulation of membrane glycoproteins can provide valuable insights into fundamental biological mechanisms and support the development of novel therapeutic strategies.
Researchers can leverage the power of AI-driven platforms like PubCompare.ai to efficiently locate the best protocols from literature, preprints, and patents, enhancing the reproducibility and accuracy of their membrane glycoprotein studies.
This can unlock new discoveries and elevate their research.
Membrane glycoproteins can be analyzed using various techniques, such as flow cytometry with FACSCalibur instruments, cell culture in DMEM media supplemented with FBS, and transfection with Lipofectamine 2000 in Opti-MEM.
Researchers may also use FITC-conjugated anti-P-selectin antibodies, Geneticin (G418 Sulfate) for selection, and DMSO for cryopreservation.
CellQuest software can be utilized for data analysis, and DAPI staining can be employed for nuclear visualization.
By incorporating these techniques and tools, researchers can gain a deeper understanding of membrane glycoproteins and their role in biological processes.